91 related articles for article (PubMed ID: 3207626)
1. The development of non-responsiveness to immunotherapy with monoclonal anti-idiotypic antibodies in a patient with B-CLL.
Allebes WA; Preijers FW; Haanen C; Capel PJ
Br J Haematol; 1988 Nov; 70(3):295-300. PubMed ID: 3207626
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with monoclonal anti-idiotypic antibodies: tumour reduction and lymphokine production.
Allebes W; Knops R; Herold M; Huber C; Haanen C; Capel P
Leuk Res; 1991; 15(4):215-22. PubMed ID: 2030602
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and functional changes of tumour cells from patients treated with monoclonal anti-idiotypic antibodies.
Allebes WA; Knops R; Bontrop RE; Otting N; Raemakers J; Haanen C; Capel PJ
Scand J Immunol; 1990 Nov; 32(5):441-9. PubMed ID: 2270431
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to idiotype inhibit in vitro growth of human B-cell lymphomas.
van Endert PM; Heilig B; Hämmerling GJ; Moldenhauer G
Blood; 1992 Jan; 79(1):129-37. PubMed ID: 1728304
[TBL] [Abstract][Full Text] [Related]
5. [Clinical application of anti-idiotypic antibody].
Yachi A; Tsujisaki M; Imai K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2313-20. PubMed ID: 2665652
[TBL] [Abstract][Full Text] [Related]
6. Shared idiotype expression by chronic lymphocytic leukemia and B-cell lymphoma.
Chatterjee M; Barcos M; Han T; Liu XL; Bernstein Z; Foon KA
Blood; 1990 Nov; 76(9):1825-9. PubMed ID: 2224130
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic lymphocytic leukemia with an anti-idiotypic monoclonal antibody.
Caulfield MJ; Murthy S; Tubbs RR; Sergi J; Bukowksi RM
Cleve Clin J Med; 1989; 56(2):182-8. PubMed ID: 2731337
[TBL] [Abstract][Full Text] [Related]
8. Production, binding characteristics, and immunogenicity of heterologous anti-idiotypic antibody to herpes simplex virus glycoprotein C.
Lathey JL; Courtney RJ; Rouse BT
Viral Immunol; 1987; 1(1):13-23. PubMed ID: 3509672
[TBL] [Abstract][Full Text] [Related]
9. Production of mouse monoclonal antibodies for the analysis of idiotypes in serum of patients with chronic lymphatic leukaemia.
de Rie MA; van Heemstra DJ; Huijgens PC; Zeijlemaker WP; Out TA; Melief CJ; von dem Borne AE
Br J Haematol; 1988 Jan; 68(1):11-6. PubMed ID: 3257881
[TBL] [Abstract][Full Text] [Related]
10. Expression in systemic lupus erythematosus of an idiotype common to DNA-binding and nonbinding monoclonal antibodies produced by normal human lymphoid cells.
Cairns E; Massicotte H; Bell DA
J Clin Invest; 1989 Mar; 83(3):1002-9. PubMed ID: 2493481
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of heat shock protein 70 (Hsp70) and idiotypic determinant single-chain antibody (Id-ScFv) in a patient with B-cell chronic lymphatic leukemia (B-CLL) and antitumor effect of peptide complex Hsp70-Id].
Ye Q; Wang ZH; Qin SK
Ai Zheng; 2008 Feb; 27(2):133-8. PubMed ID: 18279608
[TBL] [Abstract][Full Text] [Related]
12. Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon.
Brown SL; Miller RA; Horning SJ; Czerwinski D; Hart SM; McElderry R; Basham T; Warnke RA; Merigan TC; Levy R
Blood; 1989 Feb; 73(3):651-61. PubMed ID: 2465039
[TBL] [Abstract][Full Text] [Related]
13. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1990 Mar; 144(6):2436-45. PubMed ID: 1690244
[TBL] [Abstract][Full Text] [Related]
14. Idiotypic intramolecular help. Induction of tumor-specific antibodies by monoclonal anti-idiotypic antibody with the help of Fc-specific T helper clones.
Saeki Y; Chen JJ; Shi LF; Kohler H
J Immunol; 1989 Apr; 142(8):2629-34. PubMed ID: 2522964
[TBL] [Abstract][Full Text] [Related]
15. Idiotype-antiidiotype regulation. V. The requirement for immunization with antigen or monoclonal antiidiotypic antibodies for the activation of beta 2 leads to 6 and beta 2 leads to 1 polyfructosan-reactive clones in BALB/c mice treated at birth with minute amounts of anti-A48 idiotype antibodies.
Rubinstein LJ; Goldberg B; Hiernaux J; Stein KE; Bona CA
J Exp Med; 1983 Oct; 158(4):1129-44. PubMed ID: 6604783
[TBL] [Abstract][Full Text] [Related]
16. [The analysis of immunoregulation of idiotype synthesis by monoclonal anti-idiotypic antibody].
Fujisaku A
Hokkaido Igaku Zasshi; 1986 Jan; 61(1):134-45. PubMed ID: 3084367
[TBL] [Abstract][Full Text] [Related]
17. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
18. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
Qian GX; Fu SM; Solanki DL; Rai KR
J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibody.
Parker BA; Vassos AB; Halpern SE; Miller RA; Hupf H; Amox DG; Simoni JL; Starr RJ; Green MR; Royston I
Cancer Res; 1990 Feb; 50(3 Suppl):1022s-1028s. PubMed ID: 2297715
[TBL] [Abstract][Full Text] [Related]
20. Anti-idiotypes to monoclonal anti-H-2 antibodies. III. Syngeneic anti-idiotypes on antibodies induced by in vivo administration of xenogeneic anti-idiotypes.
Bluestone JA; Auchincloss H; Cazenave PA; Ozato K; Sachs DH
J Immunol; 1982 Nov; 129(5):2066-8. PubMed ID: 6981671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
